rs398122973
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001673.5(ASNS):c.1084T>G(p.Phe362Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001673.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460494Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726550
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome Pathogenic:5
The homozygous p.Phe362Val variant in ASNS was identified by our study in 1 individual with asparagine synthetase deficiency. The variant has been reported in 4 Iranian Jewish individuals with asparagine synthetase deficiency (PMID: 24139043), segregated with disease in 2 affected relatives from 2 families (PMID: 24139043), but was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 91840) as pathogenic by Invitae and OMIM, and as likely pathogenic by CeGaT Praxis fuer Humangenetik Tuebingen. In vitro functional studies provide some evidence that the p.Phe362Val variant may impact protein function (PMID: 24139043). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The presence of this variant in 5 affected homozygotes, and in 5 individuals with asparagine synthetase deficiency increases the likelihood that the p.Phe362Val variant is pathogenic (PMID: 24139043). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PM3, PP1_moderate, PS3_moderate (Richards 2015). -
- -
- -
- -
- -
not provided Pathogenic:2
- -
This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 362 of the ASNS protein (p.Phe362Val). This variant is present in population databases (rs398122973, gnomAD 0.0009%). This missense change has been observed in individuals with asparagine synthetase deficiency (PMID: 24139043). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 91840). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ASNS protein function. Experimental studies have shown that this missense change affects ASNS function (PMID: 24139043). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at